The U.S. Food and Drug Administration issued a final guidance today that, when finalized, will help standardize the data recommendations associated with in vivo blood level bioequivalence (BE) for veterinary pharmaceutical products.
via What's New: Animal & Veterinary http://ift.tt/1wJqGEf
No comments:
Post a Comment